NCT00047554View on ClinicalTrials.gov

Study of TRAVATAN in Subjects With Iris Pigmentation Changes

TerminatedOBSERVATIONAL

Enrollment

336

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost, 0.004% ophthalmic solution

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY